About CNP Pharma
CNP Pharma is a company based in Furstenzell (Germany) founded in 2007 was acquired by Capiton in July 2020. The company has 21 employees as of December 31, 2021.
- Headquarter Furstenzell, Germany
- Employees 21 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cnp Pharma Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CNP Pharma
Detailed funding history for CNP Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CNP Pharma
CNP Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include capiton.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
capiton AG is engaged in private equity investments for mid-sized companies.
|
Locked | Locked | Locked |
Investor details for CNP Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CNP Pharma
Investment portfolio details for CNP Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CNP Pharma
Detailed financials for CNP Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cnp Pharma Comparisons
Peer comparison for CNP Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CNP Pharma
Detailed competitors of CNP Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cnp Pharma
Complete news archive for CNP Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CNP Pharma
CNP Pharma was founded in 2007.
CNP Pharma is headquartered in Furstenzell, Germany. It is registered at Furstenzell, Bavaria, Germany.
As of Dec 31, 2021, the latest employee count at CNP Pharma is 21.
CNP Pharma was established in 2007 in Furstenzell, Germany, where generic drugs are produced as the core operation within the pharmaceutical sector. Manufacturing activities are focused on providing equivalents to branded medications, with processes centered in the German location. The companys online presence is maintained via the domain cnp-pharma.de, supporting distribution and information in the European market. Operations remain dedicated to regulatory-compliant production for global pharmaceutical needs.
CNP Pharma has 1 investor. Key investors include capiton.